Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer

By Havrilesky L.J.   Alvarez A.A.   Sayer R.A.   Lancaster J.M.   Soper J.T.   Berchuck A.   Clarke-Pearson D.L.   Rodriguez G.C.   Carney M.E.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 51-57

Academic Press

Access to resources Recommend Favorite

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1247-1253

Spandidos Publications

Access to resources Recommend Favorite

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis

By Takano Masashi   Sugiyama Toru   Yaegashi Nobuo   Suzuki Mitsuaki   Tsuda Hiroshi   Sagae Satoru   Udagawa Yasuhiro   Kuzuya Kazuo   Kigawa Junzo   Takeuchi Satoshi   Tsuda Hitoshi   Moriya Takuya   Kikuchi Yoshihiro  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 256-260

Springer Publishing Company

Access to resources Recommend Favorite

Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report

By                    

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3519-3522

Spandidos Publications

Access to resources Recommend Favorite

Pure primary ovarian squamous cell carcinoma: A case report and review of the literature

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 321-323

Spandidos Publications

Access to resources Recommend Favorite